Skip to main content
Dr Elsie Mensah

Dr Elsie Mensah

Consultant Urologist

General UrologyNon-Muscle-Invasive Bladder Cancer (NMIBC)Benign Prostatic Hyperplasia (BPH)

About Elsie Mensah

  • Specialty: Consultant Urologist and Urological Surgeon, subspecialising in non-muscle-invasive bladder cancer, benign prostatic enlargement and prostate cancer diagnostics

  • Conditions seen: bladder cancer, including non-muscle-invasive bladder cancer (NMIBC); enlarged prostate and benign prostatic hyperplasia (BPH); prostate cancer; urological cancer; raised PSA; lower urinary tract symptoms (LUTS); general urology

  • Tests, treatments and procedures: blue light cystoscopy, transurethral resection of bladder tumour (TURBT) including fractionated and en bloc techniques, transurethral laser ablation, image-guided transperineal prostate biopsy, prostate screening, Rezum steam ablation, Aquablation water jet therapy, holmium laser enucleation of the prostate (HoLEP)

  • Often consulted by patients with: a raised PSA result, lower urinary tract symptoms, suspected or diagnosed bladder cancer, or an enlarged prostate where surgical options are being considered

  • Patient ages seen: 18+

  • Also: 15 years of urological experience; urology tumour group lead for the South East London Cancer Alliance; council member of the International British Urology Society; on the governing body of the charity UROLAP

  • Language: English

Dr Elsie Mensah is a Consultant Urologist and Urological Surgeon at Welbeck’s Urology centre in London, specialising in non-muscle-invasive bladder cancer, benign prostate enlargement and prostate cancer diagnostics. She has significant experience in the assessment of raised PSA levels and lower urinary tract symptoms, including urinary frequency, urgency and difficulty passing urine.

Dr Mensah offers a comprehensive range of diagnostic investigations and surgical treatments tailored to each patient's condition. For bladder cancer, she performs blue light cystoscopy, transurethral resection of bladder tumour (TURBT), using both fractionated and en bloc techniques, and transurethral laser ablation. Her prostate cancer diagnostic services include prostate screening and image-guided transperineal prostate biopsy. For patients with an enlarged prostate, she offers a range of surgical options, from minimally invasive Rezum steam ablation to Aquablation water jet therapy and holmium laser enucleation of the prostate (HoLEP). Her experience across these techniques allows her to recommend treatment based on clinical findings, individual needs and patient preferences.

With 15 years of experience in urology, Dr Mensah was appointed a substantive Consultant Urological Surgeon at Guy’s and St Thomas’ NHS Foundation Trust in 2020. She is a member of the hospital’s urothelial upper tract and bladder cancer team and its benign prostatic hyperplasia team, providing specialist care for patients with complex urological conditions.

Alongside her clinical practice, Dr Mensah is the urology tumour group lead for the South East London Cancer Alliance (SELCA), working to improve cancer services and patient outcomes across the region. She is also a council member of the International British Urology Society and serves on the governing body of UROLAP, a charity supporting urological care with which she has organised urological training workshops in West Africa.

Expertise

  • General Urology
  • Non-Muscle-Invasive Bladder Cancer (NMIBC)
  • Benign Prostatic Hyperplasia (BPH)
  • Prostate
  • Urological Cancer
  • Prostate Cancer Diagnostics

Overview

Age of patients seen
18+
Qualifications

Dr Mensah graduated from King's College London School of Medicine and Dentistry. She undertook higher surgical training in Kent, Surrey and Sussex and urological training in the London Deanery, with her specialist training culminating in a final year at Guy's and St Thomas', following which she was appointed to a consultant position there in 2020. She has 15 years of urological experience.

Qualifications:

  • MBBS (Bachelor of Medicine, Bachelor of Surgery)

  • BSc (Hons) (Bachelor of Science with Honours)

  • FRCS (Urol) Eng (Fellow of the Royal College of Surgeons of England, Urology)

Languages spoken
English
Online profiles

Consultations and services

Appointments are available at 1 Welbeck Street, London W1G 0AR.

Enquire online or call 020 3653 2042.

  • Self-pay available from £300
  • Health insurance
  • 20 mins consultation

  • Self-pay available from £200
  • Health insurance
  • 20 mins consultation

Insurers covered

  • BUPA Limited

Conditions & symptoms

Locations

Loading

London

1 Welbeck Street
Marylebone
London
W1G 0AR

More information

Frequently asked questions

Non-muscle-invasive bladder cancer (NMIBC) is a type of bladder cancer that has not spread into the muscle layer of the bladder wall. Treatment usually involves removing the tumour through the urethra, without making an incision in the abdomen. Dr Mensah offers blue light cystoscopy to help identify abnormal areas of the bladder lining, alongside treatments including transurethral resection of bladder tumour (TURBT), using fractionated or en bloc techniques, and transurethral laser ablation. Depending on the type and risk of cancer, additional treatment delivered directly into the bladder and ongoing monitoring may be recommended to reduce the risk of recurrence.

Prostate-specific antigen (PSA) is a protein produced by the prostate gland that can be measured through a blood test. A raised PSA level can be a sign of prostate cancer, but it can also be caused by non-cancerous conditions, such as an enlarged prostate or inflammation. Dr Mensah has extensive experience in investigating raised PSA levels and will assess your results alongside your symptoms, medical history and other risk factors. Depending on the findings, she may recommend further tests, including an image-guided transperineal prostate biopsy, which involves taking small tissue samples from the prostate to check for cancer.

Dr Mensah offers a range of surgical treatments for benign prostatic enlargement (BPH), a non-cancerous condition in which the prostate becomes enlarged and can cause urinary symptoms such as difficulty passing urine, a weak stream or frequent urination. Her expertise includes Rezum steam ablation, which uses steam to reduce excess prostate tissue, Aquablation, which uses a precisely controlled water jet to remove tissue, and holmium laser enucleation of the prostate (HoLEP), which uses a laser to remove tissue obstructing urine flow. Dr Mensah will discuss the benefits and suitability of each approach, recommending treatment based on symptoms, prostate size and individual priorities.

All three procedures treat an enlarged prostate by reducing or removing excess prostate tissue to improve urine flow, but they use different techniques. Rezum is a minimally invasive treatment that uses steam to shrink prostate tissue over time. Aquablation uses a precisely controlled water jet to remove excess tissue, while holmium laser enucleation of the prostate (HoLEP) uses a laser to remove the tissue obstructing urine flow. Dr Mensah offers all three procedures and can explain their benefits and differences, helping you choose the most appropriate treatment based on your prostate size, symptoms and individual priorities.